Circle, the issuer of USDC, has signed an agreement to acquire Interop Labs, the original development team behind the Axelar network. The market response was immediate and violent: the AXL token shed over 15% of its value, sliding to $0.11 as holders realized the acquisition excluded the protocol’s native asset.
The Deal: Talent, Not Tokens
This is a classic “acqui-hire.” Circle is purchasing the engineering talent and proprietary intellectual property of Interop Labs to bolster its own infrastructure. According to the official announcement, the deal enables Circle to accelerate the roadmap for Arc, its upcoming institutional blockchain, and its Cross-Chain Transfer Protocol (CCTP).
Crucially, the deal excludes the Axelar Network, the Axelar Foundation, and the AXL token. These assets remain “independent,” a distinction that market participants interpreted as a signal that the original developers have secured an exit while leaving token holders with the open-source remnants.
“Veiled Rug” Fears Trigger Sell-Off
The AXL token struggled to hold support at $0.13 before capitulating to $0.11 (-15%) as volume spiked. The sharp repricing reflects a growing cynicism in crypto M&A: equity holders of the development company get paid in cash or stock, while token holders are left with a “community-governed” protocol that has lost its primary architect.
The Axelar Network, Foundation and the AXL token will continue to operate independently under community governance and open source intellectual property will remain open source.
While the Axelar Foundation attempted to calm nerves by announcing that Common Prefix, another ecosystem contributor, would take over development duties, the market viewed the transition as a downgrade in leadership continuity.
Institutional Context: Circle’s Play
For Circle, this is a strategic coup. By absorbing Interop Labs, they internalize one of the most sophisticated cross-chain engineering teams in the sector. This aligns with Circle’s shift from a mere stablecoin issuer to a full-stack infrastructure provider, positioning its Arc chain to compete directly with other institutional L1s. For AXL holders, however, the value proposition just got significantly murkier.
